Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Actavis UK’s ‘Excessive’ Price Hikes Targeted In Latest Competition Inquiry

Executive Summary

The UK competition authority has provisionally found that Actavis UK imposed “excessive” price rises on its generic version of hydrocortisone for the life-threatening condition, adrenal insufficiency. The case has similarities to the price increases on phenytoin capsules, for which Pfizer and Flynn Pharma were recently fined.

You may also be interested in...



UK Competition Regulator Steps Up Hydrocortisone Probe

Two generics firms have been provisionally found to have breached competition law by reaching agreements intended to delay the entry of competing products.

UK Competition Body Steps Up Generic Hydrocortisone Probe

Two generics firms have been provisionally found to have breached competition law by reaching agreements intended to delay the entry of competing products.

‘Excessive Pricing’ Inquiry Widens As EC’s First Antitrust Price Probe Targets Aspen Pharma

The litany of complaints against pharmaceutical companies for imposing “excessive” prices on generic drugs is growing after the European Commission decided to pursue Aspen Pharma over price rises imposed on a range of anticancer products it acquired from GSK.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

SC097887

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel